Sterling Capital Management’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMMX
SVCM
OM
Sterling Capital Management's IMMX Position: Q3 2026 in Review
Sterling Capital Management increased its Immix Biopharma (IMMX) stake by 1,267% in Q3 2026, buying an estimated $20.7K and bringing the position to 1,969 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2191.
Sterling Capital Management first reported a position in IMMX in Q2 2026 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.
- Sterling Capital Management held 1,969 shares of Immix Biopharma worth $20.5K as of Q3 2026.
- Sterling Capital Management bought 1,825 Immix Biopharma shares in Q3 2026, an estimated $20.7K.
- Immix Biopharma made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2191 holding.
- Sterling Capital Management first reported a position in Immix Biopharma in Q2 2026 and has held it in 2 quarters since.
- 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.